Cain McClary

Cain McClary, MD is the founder and Managing Partner of KdT Ventures. Over the past 10 years, Cain has been at the forefront of the intersection between computation and science. KdT has invested in companies now worth over $2B, including Zymergen, PathAI, Solugen, Dyno Therapeutics, and Firefly Bioworks (Acquired by AbCam). Additionally, Cain is personally involved in entrepreneurship and finance advisory at both the local and national levels.

Dr. McClary received a ScB in Biochemistry and Molecular Biology from Brown University and his MD from Tulane University. He completed his medical training as a pathologist at Stanford University where he served as Chief Resident and joined faculty there after training, becoming the youngest faculty member in the department at the time. Currently, Cain serves on the faculty at the Tulane University School of Medicine.